This past week seven IPOs debuted, three updated terms and two new deals filed.<\/p>\n
It was one of the strongest weeks for the IPO market this year as seven deals came to market with two of them producing gains of more than 100% just minutes after opening. Aduro Biotech (Nasdaq: ADRO)<\/b><\/strong>, after upsizing and pricing its deal above range, opened 15-points higher than the $17.00 offering price. \u2018ADRO\u2019 traded very well in its opening week and hit a high of $49.25 on its second day of trading\u2014good for a 190% gain. Aduro\u2019s performance surpasses both Shake Shack (NYSE: SHAK) and Spark Therapeutics (Nasdaq: ONCE) for best of the year 2015. Etsy (Nasdaq: ETSY) <\/b><\/strong>also doubled minutes after opening. The deal priced at the high-end of the range, $16.00, and opened 94% higher with a $31.00 first trade. Etsy traded as high as $35.74, or 123% higher, however, the deal began to sell off after the initial hour after opening and \u2018ETSY\u2019 closed its first week of trading at $27.58. \u00a0According to Bloomberg, Etsy\u2019s pop was the largest for an internet IPO since Rocket Fuel\u2019s (Nasdaq: FUEL) 93% gain at opening in August 2013. Virtu Financial (Nasdaq: VIRT) <\/b><\/strong>priced its IPO at the high end of the range, $19.00, and opened 21% higher with a first trade of $23.00. Party<\/b><\/strong> City<\/b><\/strong> HoldCo (NYSE: PRTY)<\/b><\/strong> had similar success with its high end pricing ($17.00), as the deal opened 21% higher with a $3.50 pop at first trade. Cidara Therapeutics (Nasdaq: CDTX)<\/b><\/strong> priced at the high-end of the range, $16.00, and opened just 11-cents higher with a first trade of $16.11. However, \u2018CDTX\u2019 traded well initially, hitting a first day high of $19.13, however, the IPO broke down in the after-market and traded below its offering price on week one. Cidara ended up closing the week at $15.14 . Kempharm (Nasdaq: KMPH)<\/b><\/strong> priced its offering below the range,\u00a0 $11.00, and opened at $11.75\u2014or 7% above the offering price.<\/p>\n Looking ahead to this week, there are three deals scheduled to debut and we are currently hearing early, positive street chatter about….<\/p>\n (SUBSCRIPTION NEEDED)<\/strong><\/a><\/p>\n Apigee Corporation (Nasdaq: APIC)<\/a><\/p>\n